Hormonal and reproductive factors and risk of esophageal cancer in chinese postmenopausal women: A case-control study

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 8, 2011, Pages 1953-1956

  Yu, Hui ^a   Liu, Guiyun ^a   Zhao, Peng ^a   Zhu, Liying ^a  

^a The People's Hospital of Dezhou   (China)

Author keywords

Case control study; China; Esophageal cancer; Hormonal factors; Reproductive factors

Indexed keywords

EID: 84863291546     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Akgun H, Lechago J, Younes M (2002). Estrogen receptor-beta is expressed in Barrett's metaplasia and associated adenocarcinoma of the esophagus. Anticancer Res, 22, 1459-61.
2. Battin DA, Marrs RP, Fleiss PM, et al (1985). Effect of suckling on serum prolactin, luteinizing hormone, follicle-stimulating hormone, and estradiol during prolonged lactation. Obstet Gynecol, 65, 785-8.
3. Blount BC, Mack MM, Wehr CM, et al (2007). Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A, 94, 3290-5.
4. International Agency for Research on Cancer (2011). IARC Cancer Epidemiology Database. http://www.iarc.fr/en/websites/databases.php.
5. Chen ZH, Shao JL, Lin JR, et al (2011). Reproductive factors and oesophageal cancer in Chinese women: a case-control study. BMC Gastroenterol, 11, 49.
6. Cheng KK, Sharp L, McKinney PA, et al (2000). A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer, 83, 127-32.
7. Cronin-Fenton DP, Murray LJ, Whiteman DC, et al (2010). Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur J Cancer, 46, 2067-76.
8. Engel LS, Chow WH, Vaughan TL, et al (2003). Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst, 95, 1404-13.
9. Heuch I, Jacobsen BK, Albreksen G, et al (2008). Reproductive factors and pancreatic cancer risk: a Norwegian cohort study. Br J Cancer, 106, 982-3.
10. Heuch I, Kvale G (2003). Dose breastfeeding affect the risk of gastric cancer. Int J Cancer, 106, 982-3.
11. Inoue M, Ito LS, Tajima K, et al (2002). Height, weight, menstrual and reproductive factors and risk of gastric cancer among Japanese postmenopausal women: analysis by subsite and histologic subtype. Int J Cancer, 97, 833-8.
12. Lagergren J, Jansson C (2005). Sex hormones and oesophageal adenocarcinoma: influence of childbearing? Br J Cancer, 93, 859-61.
13. Lindblad M, García Rodríguez LA, Chandanos E, et al (2006). Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer, 94, 136-41.
14. Monstein HJ, Grahn N, Truedsson M, et al (2004). Oxytocin and oxytocin-receptor mRNA expression in the human gastrointestinal tract: a polymerase chain reaction study. Regul Pept, 119, 39-44.
15. Nilsson M, Johnsen R, Ye W, et al (2003). Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA, 290, 66-72.
16. Parkin DM, Bray F, Ferlay J, et al (2005). Global Cancer Statistics 2002. CA Cancer J. Clin, 55, 74-108.
17. Raouf AA, Evoy DA, Carton E, et al (2003). Loss of Bcl-2 expression in Barrett's dysplasia and adenocarcinoma is associated with tumor progression and worse survival but not with response to neoadjuvant chemoradiation. Dis Esophagus, 16, 17-23.
18. Tiffin N, suvarna SK, Trudgill NJ, et al (2003). Sex hormone receptor immunohistochemistry staining in Barrett's oesophagus and adenocarcinoma. Histopathology, 42, 95-6.
19. Tihan T, Harmon JW, Wan X, et al (2001). Evidence of androgen receptor expression in squamous and adenocarcinoma of the esophagus. Anticancer Res, 21, 3107-14.
20. Utsumi Y, Nakamura T, Nagasue N, et al (1989). Role of estrogen receptors in the growth of human esophageal carcinoma. Cancer, 64, 88-93.
21. Vizcaino AP, Moreno V, Lambert R, et al (2001). Time trends incidence of both major histological types of esophageal carcinomas in selected counties. Int J Cancer, 99, 860-8.